Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection

European Journal of Clinical Microbiology & Infectious Diseases

Volumn 13, Issue 2 Supplement, 1994, Pages

  Bodey, G P ^a   Anaissie, E ^a   Gutterman, J ^a   Vadhan Raj, S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CLAVULANIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NETILMICIN; TICARCILLIN; TIMENTIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; BACTERIAL INFECTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG THERAPY, COMBINATION; FEMALE; FUNGEMIA; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0028079761     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/BF01973597     Document Type: Article

References (10)

1. Pulmonary complications of acute leukaemia
2. Fungal infections complicating acute leukaemia
3. The problem of infection in children with malignant disease
4. Systemic candidiasis in cancer patients
5. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes
6. Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma
7. Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas
8. VIP chemotherapy with/without GM-CSF for poor risk, relapsed or refractory germ cell tumours: preliminary analysis of a randomized controlled trial
9. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer
10. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus